Combretastatin A-1
Combretastatin A-1 is a potent microtubule inhibitor with anti-tumour and anti-vascular activity, acting through microtubule protein depolymerisation-mediated inactivation of AKT to inhibit the Wnt/β-catenin pathway, and can be used to study hepatocellular carcinoma.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
332.35
Molecular Formula
C18H20O6
Notes
Research use only, not for human use.
Receptor
Microtubule Associated | Akt
CAS Number
109971-63-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
13245141 1x10<sup>6</sup> cells/1.0ml
BCL7B CRISPR Knock Out 293T Cell Line (Human)
Ask
View Details 
MBS6156276-01 0.1 mL
RhoE (Rho-related GTP Binding Protein RhoE, Rnd3, Protein MemB, Rho Family GTPase 3, Rho-related GTP-binding Protein Rho8, Rnd3, ARHE, RHO8) (PE)
Ask
View Details MBS6156276-02 5x 0.1 mL
RhoE (Rho-related GTP Binding Protein RhoE, Rnd3, Protein MemB, Rho Family GTPase 3, Rho-related GTP-binding Protein Rho8, Rnd3, ARHE, RHO8) (PE)
Ask
View Details 